Cargando…

Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: A new generation P2Y12 receptor inhibitor (ticagrelor) is recommended in current therapeutic guidelines to treat patients with coronary heart disease (CHD). However, it is unknown if ticagrelor is more effective than clopidogrel in elderly patients. Therefore, a systematic review was don...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akkaif, Mohammed Ahmed, Sha’aban, Abubakar, Daud, Nur Aizati Athirah, Yunusa, Ismaeel, Ng, Mei Li, Sk Abdul Kader, Muhamad Ali, Noor, Dzul Azri Mohamed, Ibrahim, Baharudin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538993/ https://www.ncbi.nlm.nih.gov/pubmed/34677192 http://dx.doi.org/10.3390/jcdd8100123

Ejemplares similares

The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD)
por: Akkaif, Mohammed Ahmed, et al.
Publicado: (2021)

The Management of Myocardial Injury Related to SARS-CoV-2 Pneumonia
por: Akkaif, Mohammed Ahmed, et al.
Publicado: (2022)

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
por: Amin, Arwa M., et al.
Publicado: (2017)

Association between CYP3A4/CYP3A5 genetic polymorphisms and treatment outcomes of atorvastatin worldwide: is there enough research on the Egyptian population?
por: Maslub, Mohammed G., et al.
Publicado: (2023)

The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review
por: Akkaif, Mohammed Ahmed, et al.
Publicado: (2022)

Assessment of COVID-19 Information Overload Among the General Public
por: Mohammed, Mustapha, et al.
Publicado: (2021)

Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions
por: Ahmed, Ali Fadhel, et al.
Publicado: (2021)

Knowledge, attitude and perception of community pharmacists towards pharmacogenomics services in northern Nigeria: a cross-sectional study
por: Abubakar, Usman, et al.
Publicado: (2022)

Choosing between ticagrelor and clopidogrel following percutaneous coronary intervention: A systematic review and Meta-Analysis (2007–2017)
por: Guan, Wenjun, et al.
Publicado: (2018)

Ticagrelor as an Alternative for Clopidogrel-Associated Acute Arthritis
por: Bedy, Starr-Mar'ee C., et al.
Publicado: (2018)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Volney, Candice, et al.
Publicado: (2019)

Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence
por: Kumar, Viveka, et al.
Publicado: (2018)

Hypersensitivity to ticagrelor and low response to clopidogrel: a case report
por: Dai, Jing, et al.
Publicado: (2017)

Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of Treatment
por: Bergmeijer, Thomas O., et al.
Publicado: (2018)

Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
por: Lomakin, Nikita, et al.
Publicado: (2019)

Temporal Variability of Platelet Reactivity in Patients Treated with Clopidogrel or Ticagrelor
por: Yun, Kyeong Ho, et al.
Publicado: (2019)

Comparison of ticagrelor and clopidogrel on platelet function and prognosis in unstable angina
por: Li, Chun, et al.
Publicado: (2022)

Antihypertensive Medications for Severe Hypertension in Pregnancy: A Systematic Review and Meta-Analysis
por: Awaludin, Adila, et al.
Publicado: (2022)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

Real‐World Comparison of Ticagrelor and Clopidogrel: Rosetta Stone or Lost in Translation?
por: Bergmark, Brian A.
Publicado: (2020)

Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome
por: Moon, Hyeyeon, et al.
Publicado: (2021)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
por: Scanavini-Filho, Marco Antonio, et al.
Publicado: (2022)

Aspirin/clopidogrel/ticagrelor: Diffuse ooze and bleeding: 2 case reports
Publicado: (2021)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
por: Peasah, Samuel K., et al.
Publicado: (2023)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
por: Yao, Ying, et al.
Publicado: (2019)

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
por: Grima, Daniel T, et al.
Publicado: (2014)

Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
por: Chang, Hyoung Woo, et al.
Publicado: (2019)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome
por: Liu, Lin, et al.
Publicado: (2018)

Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease
por: Vlachopoulos, Charalambos, et al.
Publicado: (2019)

Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor
por: Carino, Annarita, et al.
Publicado: (2016)

Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020)

The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
por: Choi, Woong Gil, et al.
Publicado: (2021)

Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
por: Petousis, Stylianos, et al.
Publicado: (2022)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2023)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

A Comparative Pharmacodynamic Study of Ticagrelor versus Clopidogrel and Ticagrelor in Patients Undergoing Primary Percutaneous Coronary Intervention: The CAPITAL RELOAD Study
por: Hibbert, Benjamin, et al.
Publicado: (2014)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome: Erratum
Publicado: (2018)

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
por: Wang, Dong, et al.
Publicado: (2018)

Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trial
por: Bellavia, Andrea, et al.
Publicado: (2017)

Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel
por: ALGÜL, Engin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4pgkln5kvpb7na56l23qfdf1c0